x
We are a team of passionate neuroscientists, engineers, and medical innovators working together to transform lives through brain-computer interface technology. Our journey began at Switzerland's Wyss Center, where groundbreaking research meets real-world impact. Today, we are dedicated to developing BCI solutions that help patients regain independence and reconnect with their world.
Bringing extensive leadership roles in the neurotechnology industry, Rotem Kopel has pioneered breakthroughs at the intersection of neuroscience, AI, and medical technology, with a proven track record of transforming innovative technologies into practical healthcare solutions.
A member of the World Economic Forum's Global Future Councils, she previously served as CTO of Luciole Medical and Partner at Cukierman & Co. Life Sciences. Rotem holds a Ph.D. in Neuroscience and Electrical Engineering from EPFL.
Jonas Zimmermann is a neuroscientist specializing in brain-computer interfaces and movement restoration technology. At the Wyss Center for Bio and Neuroengineering, he spearheaded the development of the ABILITY system for severe paralysis and locked-in conditions.
With over fifteen years of experience in human and animal neuroscience, Jonas brings comprehensive expertise across multiple neural technologies, including multielectrode arrays and optogenetic stimulation. He holds a Ph.D. from Newcastle University focused on spinal cord stimulation.
Arnau Espinosa is a pioneering neurotechnology expert specializing in neural signal processing and medical device development. He led the ABILITY system design and stroke rehabilitation initiatives at the Wyss Center, building on his extensive experience from Philips Research and g.tec medical engineering.
Arnau's expertise spans BCI development, medical device regulation, and the successful commercialization of neurotechnology products. He holds a master's degree in telecommunications engineering from the Polytechnic University of Catalonia.
David Ibáñez is a distinguished neuroscientist and engineer specializing in neural signal processing and machine learning for BCI applications. At the Wyss Center, he led the development of ABILITY's real-time processing algorithms and neural decoding platform. His expertise spans advanced AI algorithms, multimodal physiological data analysis, and clinical implementation of neurotechnology.
Previously at Starlab Barcelona and Neuroelectrics, David pioneered brain monitoring and stimulation technologies. He holds a Ph.D. in Biomedicine from Universitat Pompeu Fabra and dual master's degrees in Biomedical Engineering and Telecommunications.
Professor Hagai Bergman is one of the founding fathers of Deep Brain Stimulation (DBS), world-renowned neurosurgeon and neuroscientist with unparalleled expertise in electrophysiology recordings and therapeutics.
He is a leading authority on the computational physiology of the basal ganglia, their disorders, and therapeutic interventions.
A pioneer in BCIs and stroke rehabilitation, Professor José Millán has contributed several seminal advancements in brain-machine interfaces and brain-controlled robotics.
He is a highly decorated researcher, recognized with prestigious honors such as the IEEE-SMC Norbert Wiener Award (2011), elevation to IEEE Fellow (2017), and election as a Fellow of the International Academy of Medical and Biological Engineering (2020).
A big data and bioinformatics visionary, Gabriel Eichler is known for his groundbreaking work in real-world data analytics.
As the former Vice President and Worldwide Head of Data for Novartis R&D, he spearheaded the revolutionary Data42 project. Eichler also leads data and analytics efforts at the Harvard Business School’s Kraft Precision Medicine Accelerator and brings strategic insights from his experience at McKinsey & Company.
Professor Erwin Böttinger is a neurotechnology impact visionary and the Director of the Wyss Center for Bio- and Neuroengineering in Geneva, Switzerland.
With dual professorships in Medicine and Artificial Intelligence at the Icahn School of Medicine at Mount Sinai, Professor Böttinger has spearheaded numerous initiatives in personalized medicine, digital health, and neurotechnology.
His leadership roles include founding the Digital Health Center at the Hasso Plattner Institute and serving as CEO of the Berlin Institute of Health. He is renowned for establishing the Mount Sinai BioMe™ Biobank and pioneering contributions to clinical innovation in neurological and mental health disorders.
Tracy Laabs is a visionary leader in neurotechnology, with deep expertise in BCIs and translational neuroscience.
As the founding Deputy Director of the Wyss Center, she has been instrumental in transforming it into an internationally renowned hub for neurotechnology innovation.
Her work focuses on accelerating the translation of groundbreaking science from the lab to clinical applications, driving global impact.
